Clin2
NCT06866236Possibly a fitNot yet recruiting

New drug QRX-3 for chronic kidney disease

Chronic Kidney DiseasesAcute Kidney InjuryKidney Failure

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests a new drug called QRX-3 to see if it can prevent or slow down kidney disease. It is for people whose kidney function is moderately low and getting worse, but not too quickly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
3,000 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You have been diagnosed with chronic kidney disease
  • Your kidney function (eGFR) is less than 60 ml/min
  • Your kidney function has been going down over the past year
  • Your kidney function has not dropped more than 20% in the last year
  • No other obvious cause for your kidney disease has been found
  • You are able and willing to attend follow-up visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07430930Not yet recruiting
Message trial for chronic kidney disease treatment

This study tests if sending reminders to doctors helps improve treatment for chronic kidney disease. It looks at several medicines that can help protect your kidneys.

New Haven, Connecticut
NCT06058585Recruiting· Phase 3
Testing new drugs for chronic kidney disease

This trial tests different medicines to see if they can slow down kidney disease. You may be able to join if you have chronic kidney disease and are already getting standard treatment.

Garran, Australian Capital Territory
NCT07161843Not yet recruiting· Phase 2/Phase 3
Testing QRX3 for kidney failure in hospitalized patients

This trial tests a new drug, QRX3, for a specific type of sudden kidney failure (acute tubular necrosis) in hospitalized patients. It aims to see if the drug can help improve kidney function.

Rosharon, Texas
NCT07419828Recruiting· Phase 3
Study of HRS-1780 for chronic kidney disease

This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.

Nanjing, Jiangsu
NCT07348237Recruiting· Phase 1
Testing a new kidney disease drug in patients with kidney failure

This trial tests the safety of a new medicine (MK-2828) in people with advanced kidney disease or on dialysis, and compares them to healthy volunteers. The goal is to understand how the drug works in the body and if it's safe for these patients.

Miami Lakes, Florida
NCT07237295Recruiting
CommunityRx Kidney Health Support Program

This study is testing a program called CommunityRx that gives kidney health information and resources to people with chronic kidney disease. It aims to help you better manage your condition between doctor visits.

Beulaville, North Carolina

Hear when a new Acute Kidney Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.